Cargando…
Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation
Autor principal: | Dimitroulas, Theodoros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628872/ https://www.ncbi.nlm.nih.gov/pubmed/37941867 http://dx.doi.org/10.31138/mjr.20230929.taa |
Ejemplares similares
-
Atopic dermatitis: Tofacitinib, an option for refractory disease
por: Berbert Ferreira, Sineida, et al.
Publicado: (2020) -
Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2020) -
Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018) -
Treatment Options in Refractory Autoimmune Encephalitis
por: Dinoto, Alessandro, et al.
Publicado: (2022) -
Unilateral Bluish Sclera
por: Hari Kumar, K. V. S., et al.
Publicado: (2018)